CCS Healthcare has entered into agreements to divest its Consumer Skincare business unit. CCS’s factory and contract manufacturing activities in Borlänge, Sweden, will be sold to Svenska Krämfabriken AB and the Group’s portfolio of skincare brands sold in Sweden, Norway, Finland and the UK will be acquired by Trimb Healthcare AB.
Following the divestments, CCS will be exclusively focused on hygiene and safety products in the professional business-to-business markets.
The transactions are expected to be completed in January 2019.
CCS Healthcare is a portfolio company of Segulah IV L.P.
For further information, please visit www.ccshc.com, www.segulah.com or contact:
Johan Möllerström, Investment Manager, Segulah Advisor AB, +46 72 543 79 11